amylase 30250 UNT / lipase 8000 UNT / protease 28750 UNT Delayed Release Oral Capsule
RxNorm concept 1294481, clinical drug (scd). Prescribable name: lipase 8000 UNT / amylase 30,250 UNT / protease 28,750 UNT Delayed Release Oral Capsule.
- RxCUI
- 1294481
- Term type
- Clinical drug (SCD)
- Status
- Active
curl https://api.healthcare.dev/v1/drugs/rxnorm/1294481 \ -H "Authorization: Bearer $HDEV_API_KEY"
Concept
Ingredients and related concepts
Ingredients
Other names
amylase 30,250 UNT / lipase 8,000 UNT / protease 28,750 UNT Delayed Release Oral Capsule; amylases 30,250 UNT / endopeptidases 28,750 UNT / lipase 8000 UNT Delayed Release Oral Capsule
Related concepts
- lipase 8000 UNT (SCDC, consists of)
- amylase 30250 UNT (SCDC, consists of)
- protease 28750 UNT (SCDC, consists of)
- Delayed Release Oral Capsule (DF, has dose form)
- amylase 30250 UNT / lipase 8000 UNT / protease 28750 UNT Delayed Release Oral Capsule [Pertzye] (SBD, has tradename)
Linked data
NDCs
RxNorm links no NDCs to this concept.
Use it
Look up 1294481 from code or an agent
curl https://api.healthcare.dev/v1/drugs/rxnorm/1294481 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up RxNorm concept 1294481. Tell me its name and term type, its ingredients and related concepts, and the NDCs linked to it.
Source: U.S. National Library of Medicine, release 2026-10-05. No license required (Current Prescribable Content). Reference data, not medical advice.